Cargando…

A compound heterozygous mutation in HADHB gene causes an axonal Charcot-Marie-tooth disease

BACKGROUND: Charcot-Marie-Tooth disease (CMT) is a heterogeneous disorder of the peripheral nervous system. So far, mutations in hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit (HADHB) gene exhibit three distinctive phenotypes: severe n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Young Bin, Lee, Ja Hyun, Park, Jin-Mo, Choi, Yu-Ri, Hyun, Young Se, Yoon, Bo Ram, Yoo, Jeong Hyun, Koo, Heasoo, Jung, Sung-Chul, Chung, Ki Wha, Choi, Byung-Ok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029087/ https://www.ncbi.nlm.nih.gov/pubmed/24314034 http://dx.doi.org/10.1186/1471-2350-14-125

Ejemplares similares

A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy
por: Hong, Young Bin, et al.
Publicado: (2016)

Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease
por: Kim, Hyeon Jin, et al.
Publicado: (2013)

Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations
por: Kim, Hyun Su, et al.
Publicado: (2021)

Phenotypic heterogeneity in patients with NEFL‐related Charcot–Marie–Tooth disease
por: Kim, Hye Jin, et al.
Publicado: (2022)

Charcot-Marie-Tooth 1A Concurrent with Schwannomas of the Spinal Cord and Median Nerve
por: Kwon, Joo Young, et al.
Publicado: (2009)

A Compound Heterozygous Pathogenic Variant in B4GALNT1 Is Associated With Axonal Charcot-Marie-Tooth Disease
por: Hong, Ji-Man, et al.
Publicado: (2021)

Whole-genome sequencing in clinically diagnosed Charcot–Marie–Tooth disease undiagnosed by whole-exome sequencing
por: Kim, Young-gon, et al.
Publicado: (2023)

Charcot-Marie-Tooth Disease: Seventeen Causative Genes
por: Lee, Jung-Hwa, et al.
Publicado: (2006)

Clinical and Neuroimaging Features in Charcot–Marie–Tooth Patients with GNB4 Mutations
por: Kwon, Hye Mi, et al.
Publicado: (2021)

Novel Compound Heterozygous Nonsense PRX Mutations in a Korean Dejerine-Sottas Neuropathy Family
por: Choi, Ye Ji, et al.
Publicado: (2015)

Novel homozygous mutations in Pakistani families with Charcot–Marie–Tooth disease
por: Kanwal, Sumaira, et al.
Publicado: (2021)

Foot Deformity in Charcot Marie Tooth Disease According to Disease Severity
por: Joo, So Young, et al.
Publicado: (2011)

Gait Pattern in Charcot-Marie-Tooth Disease Type 1A According to Disease Severity
por: Park, Jihyun, et al.
Publicado: (2023)

Cerebellar White Matter Abnormalities in Charcot–Marie–Tooth Disease: A Combined Volumetry and Diffusion Tensor Imaging Analysis
por: Hwang, Sungeun, et al.
Publicado: (2021)

Genetic and clinical spectrums in Korean Charcot‐Marie‐Tooth disease patients with myelin protein zero mutations
por: Kim, Hye Jin, et al.
Publicado: (2021)

Muscle fat quantification using magnetic resonance imaging: case–control study of Charcot–Marie–Tooth disease patients and volunteers
por: Kim, Hyun Su, et al.
Publicado: (2019)

Farnesol Ameliorates Demyelinating Phenotype in a Cellular and Animal Model of Charcot-Marie-Tooth Disease Type 1A
por: Park, Na-Young, et al.
Publicado: (2021)

Magnetic resonance imaging-based lower limb muscle evaluation in Charcot-Marie-Tooth disease type 1A patients and its correlation with clinical data
por: Kim, Yeo Jin, et al.
Publicado: (2022)

Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease
por: Pedroso, José Luiz, et al.
Publicado: (2015)

Case series: Childhood Charcot-Marie-Tooth: Predominance of axonal subtype
por: Thongsing, Apirada, et al.
Publicado: (2019)

Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients
por: Jung, Na Young, et al.
Publicado: (2022)

Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1
por: LEE, JINHO, et al.
Publicado: (2016)

Gait parameters as tools for analyzing phenotypic alterations of a mouse model of Charcot-Marie-Tooth disease
por: Hwang, Sun Hee, et al.
Publicado: (2021)

Intraepineurial fat quantification and cross-sectional area analysis of the sciatic nerve using MRI in Charcot-Marie-Tooth disease type 1A patients
por: Kim, Hyun Su, et al.
Publicado: (2021)

Anesthesia in a patient with Charcot-Marie-Tooth disease with pneumothorax: a case report
por: Kim, Jae Won, et al.
Publicado: (2019)

Hidden hearing loss in patients with Charcot-Marie-Tooth disease type 1A
por: Choi, Ji Eun, et al.
Publicado: (2018)

Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009)

Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication
por: Kim, Young Hwa, et al.
Publicado: (2012)

Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease
por: Lee, Hyoung-Song, et al.
Publicado: (2013)

Erratum: Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication
por: Kim, Young Hwa, et al.
Publicado: (2012)

Charcot–Marie–Tooth disease and intracellular traffic
por: Bucci, Cecilia, et al.
Publicado: (2012)

Noncompaction Cardiomyopathy with Charcot-Marie-Tooth Disease
por: Eltawansy, Sherif Ali, et al.
Publicado: (2015)

Anejaculation in a patient with Charcot–Marie–Tooth
por: Cannarella, Rossella, et al.
Publicado: (2018)

Charcot-Marie-Tooth: From Molecules to Therapy
por: Morena, Jonathan, et al.
Publicado: (2019)

Audiological findings in the Charcot-Marie-Tooth Disease
por: Fukushima, Erika, et al.
Publicado: (2015)

Novel heterozygous variants of SLC12A6 in Japanese families with Charcot–Marie–Tooth disease
por: Ando, Masahiro, et al.
Publicado: (2022)

Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal Neuropathy
por: Sames, Lori, et al.
Publicado: (2014)

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
por: Benoy, Veronick, et al.
Publicado: (2016)

One Multilocus Genomic Variation Is Responsible for a Severe Charcot–Marie–Tooth Axonal Form
por: Miressi, Federica, et al.
Publicado: (2020)

Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy
por: Mo, Zhongying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_japf6ff5uf5edcdlfpq7ij98af